356 related articles for article (PubMed ID: 2123203)
1. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci.
Strock LL; Lee MM; Rutan RL; Desai MH; Robson MC; Herndon DN; Heggers JP
J Burn Care Rehabil; 1990; 11(5):454-9. PubMed ID: 2123203
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods.
Rodgers GL; Mortensen JE; Fisher MC; Long SS
J Burn Care Rehabil; 1997; 18(5):406-10. PubMed ID: 9313120
[TBL] [Abstract][Full Text] [Related]
3. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].
Cui S; Han L; Xiao S; Chen X; Chang Q; Liu Y; Zhang X
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):21-4. PubMed ID: 24684985
[TBL] [Abstract][Full Text] [Related]
5. The use of Bactroban for infection management in burn patients.
Vrtisková J; Königová R
Acta Chir Plast; 1990; 32(1):57-60. PubMed ID: 1694623
[TBL] [Abstract][Full Text] [Related]
6. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
[TBL] [Abstract][Full Text] [Related]
7. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
8. Mupirocin: a topical antibiotic with a unique structure and mechanism of action.
Parenti MA; Hatfield SM; Leyden JJ
Clin Pharm; 1987 Oct; 6(10):761-70. PubMed ID: 3146455
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.
Rode H; Hanslo D; de Wet PM; Millar AJ; Cywes S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1358-61. PubMed ID: 2508545
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
[TBL] [Abstract][Full Text] [Related]
11. Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?
Neely AN; Gardner J; Durkee P; Warden GD; Greenhalgh DG; Gallagher JJ; Herndon DN; Tompkins RG; Kagan RJ
J Burn Care Res; 2009; 30(1):19-29. PubMed ID: 19060725
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate, against staphylococci and gram-negative bacteria.
Marone P; Monzillo V; Perversi L; Carretto E
J Chemother; 1998 Feb; 10(1):17-21. PubMed ID: 9531070
[TBL] [Abstract][Full Text] [Related]
13. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients.
Glasser JS; Guymon CH; Mende K; Wolf SE; Hospenthal DR; Murray CK
Burns; 2010 Dec; 36(8):1172-84. PubMed ID: 20542641
[TBL] [Abstract][Full Text] [Related]
14. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
[TBL] [Abstract][Full Text] [Related]
15. [Methicillin-resistant Staphylococcus aureus infection and its treatment in burned patients].
Huan JN; Chen YL; Ge SD
Zhonghua Wai Ke Za Zhi; 1994 Apr; 32(4):244-5. PubMed ID: 7842932
[TBL] [Abstract][Full Text] [Related]
16. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
Acikel C; Oncul O; Ulkur E; Bayram I; Celikoz B; Cavuslu S
J Burn Care Rehabil; 2003; 24(1):37-41. PubMed ID: 12543989
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility testing of meticillin-resistant and meticillin-susceptible staphylococci to mupirocin and novobiocin.
Fulham KS; Lemarie SL; Hosgood G; Dick HL
Vet Dermatol; 2011 Feb; 22(1):88-94. PubMed ID: 21039985
[TBL] [Abstract][Full Text] [Related]
18. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.
Valentine BK; Dew W; Yu A; Weese JS
Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904
[TBL] [Abstract][Full Text] [Related]
20. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
Rode H; de Wet PM; Davies MR; Cywes S
Prog Pediatr Surg; 1981; 14():189-208. PubMed ID: 7221007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
